Claim OwnershipInside Global Pharma
Subscribed: 13Played: 173
Subscribe
© All rights reserved
Description
Thought leadership for Pharmaceutical and MedTech executives
20 Episodes
Reverse
In this podcast, Jennifer Curtis and David Jackson share valuable insights on global commercial excellence. They highlight strategies to optimize product launches and maximize revenue potential based on recent research conducted by ZS on the top 25 pharma companies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: David Jackson
In this episode, ZS leaders Jennifer Curtis, Pranav Srivastava and Surbhi Puri discuss customer experience in cell and gene therapy, drawing on recent ZS patient experience study outcomes.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: Pranav Srivastava and Surbhi Puri
Jennifer Curtis discusses with Cody Powers and Nan Wang their latest research on how to drive stronger global strategy, focusing on the trends in in early- and late-stage pharma acquisitions.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Sophie McManus
Featuring: Nan Wang and Cody Powers
When most global pharmaceutical launches are as likely to underperform as overperform, how can leaders ensure they prepare their organizations for success? On this episode of Inside Global Pharma, ZS leaders Jennifer Curtis and Maria Whitman share their perspectives on the next era of global launch and where leaders should be investing to set up their organizations for success.
Be sure to also download the latest ZS podcast, Transforming Biopharma by ZS, hosted by Maria Whitman.
Additional Details
https://www.pm360online.com/global-biopharma-launches-in-the-new-world-order/
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: Maria Whitman
1Our latest episode on Oncology Portfolio Strategy features Josh Hattem sharing insights into the oncology therapeutic area and implications of different customer lenses on portfolio design and strategy. This episode builds on concepts addressed in a previous Inside Global Pharma episode, The Value of Focus.
Hosted by: Jennifer Curtis
Produced by: Matilda Males & Sophie McManus
Featuring: Josh Hattem
Jennifer Curtis and Ben Hohn discuss trends in emerging pharma commercialization.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Ben Hohn
Jennifer Curtis, Tina Shepley and Hensley Evans discuss the importance of patient centricity in market shaping for a successful product launch.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Hensley Evans and Tina Shepley
Jennifer Curtis and Jeffrey Moore discuss recent ZS insights and trends in #customerengagement
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Jeffrey Moore
The road to commercializing cell and gene therapies was long, but during the last years we have observed strong market growth and a very crowded pipeline. In this episode, we discuss more challenges and what it takes to successfully launch and commercialize these advanced therapies.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Sankalp Sethi
In light of World AIDS Day 2021, in this episode of ‘Inside Global Pharma’ we focus on the journey to eradicating AIDS and discuss themes of inequality today and how they can be managed.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Sophie McManus
Featuring: Mark Saunders and Bill Coyle
We immersed ourselves in R&D to discuss what drives clinical trial success beyond the science alone. Join us to learn what it means to be human-centric in the context of clinical trials, and how human-centric principles and cognitive science can aid trial recruitment and execution.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Sophie McManus
Featuring: Chris Crabtree and Jacob Braude
In this episode we are exploring the role of medical affairs in shaping stakeholder engagement strategies across both traditional and digital channels and what this means for the future of medical affairs.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Bora Erdemli and Sarah Jarvis
Customer engagement has been a hot topic across pharma med tech companies, even before the pandemic. In this episode, we discuss the future of customer engagement and how can companies deliver consistent, relevant, and positive experience in digital, in-person and hybrid world.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Jude Konzelmann and Heather Wiederholt
In this episode, our guest is Josh Hattem discussing insights from recent research on the value of focus in portfolio strategy for biopharmaceutical companies. Highlights from the episode include:
- Defining what is a portfolio strategy within a biopharmaceutical company
- Why focus can provide a competitive edge but companies often fail to maximize the benefits
- Implications on how to align R&D and commercial strategy to drive pipeline investment and greater commercial success
Additional details – Article published on InVivo (March 2021) https://invivo.pharmaintelligence.informa.com/IV124716/The-Value-And-Challenge-Of-Focus-In-Pharma
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Joshua Hattem
COVID-19 has pushed the idea of scenario planning to the forefront. It is becoming increasingly important to be able to anticipate and plan for the unexpected by looking at the extremes, and how they could change the business. In this episode we focus on oncology and discuss three different worlds that could emerge in the future and implications on pharma’s business strategy.
Hosted by: Matilda Males
Produced by: Matilda Males
Featuring: Jennifer Curtis and Malik Kaman
Cancer has been progressively redefined over the past 20 years. One of the most active pipelines is immunotherapy, with almost 300 molecules in phase one or phase two trials. In this episode we are discussing if existing immunotherapies have lived up to the expectations and what will drive success for the next wave of products in this evolving market.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Rohan Giblin
Featuring: Malik Kaman, Jon Roffman, Sharon Karlsberg
COVID-19 has accelerated many trends that were only starting to emerge in healthcare before 2020. It led to an inflection point, bringing in new opportunities and challenges in how pharma and medtech companies serve patients and other customers. Here, we set to explore COVID-19 not just as a unique event and implications specific to it, but more as the wider trends we anticipate playing out and how pharma and medtech companies need to prepare and invest to win in the future.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Brian Chapman, David Jackson, Mark Saunders
Patient centricity is a topic that has been floating around healthcare organizations for the better part of the last decade. Most healthcare companies have something about patients in their mission statement or vision. However, although the patients are the ultimate customers in the healthcare landscape, they may not always be in the forefront. In this episode we talk with two ZS leaders to hear their perspective on what patient centricity really means and what organizations can do today to become more patient centric.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Rohan Giblin
Featuring: Hensley Evans, Gordon Bache
The oncology pharmaceutical landscape is exploding – both in revenue and competition. Integrated, customer-centric brand strategies provide an opportunity to stand out from the competition by delivering more customer value. Our host, Jennifer Curtis, a leader in our European Marketing Practice, speaks with leaders in ZS’ oncology, marketing and market access practices to identify the key success factors in delivering a customer-centric global brand strategy.
Hosted by: Jennifer Curtis
Produced by: Matilda Males and Rohan Giblin
Featuring: Malik Kaman, Kurt Kessler, Smita Sealey
Over the last decade the combination of high unmet patient need and revenue potential has resulted in companies of all sizes moving into the Oncology space. Now competition is fierce and the pathway to success has many obstacles. There are more and more “me-too”, less clinically differentiated assets competing the same space with high prices. So, what is a pharma company to do when talking about the data is just not enough to win? In this podcast three ZS experts share insights on how to compete in this landscape.
Hosted by: Jennifer Curtis
Produced by: Matilda Males
Featuring: Pranav Srivastava, Bill Coyle, Falko Graf-Meisner
Comments
Download from Google Play
Download from App Store
United States